Postdoctoral researcher with extensive experience with the design and preclinical testing of immune-modulating cancer vaccines joins Immunitrack

We are delighted to announce that Mie Linder Hübbe will join Immunitrack as a postdoctoral researcher in collaboration with Professor Mads Hald Andersen at the National Center for Cancer Immune Therapy (CCIT-DK) in Copenhagen, Denmark.

Mie completed a PhD at the Technical University of Denmark in 2019 under the supervision of Professor Thomas Andresen. Since then she has conducted postdoctoral research at CCIT-DK under the supervision of Professor Mads Hald Andersen. She has extensive experience with the design and preclinical testing of immune-modulating cancer vaccines.

Mie’s main focus at Immunitrack will be to find new cancer targets for immunotherapy. Her work will further bridge and strengthen the existing collaboration between Immunitrack and CCIT-DK and will contribute to developing better cancer treatments. We welcome her to the Immunitrack family.